Transcatheter aortic valve implantation in a young heart transplant recipient crossing the traditional boundaries.
Transcatheter aortic valve implantation (TAVI) is an established therapeutic alternative to surgical aortic valve replacement (SAVR) in high-risk or inoperable patients with symptomatic aortic valve stenosis. Hitherto, TAVI is not recommended in young and low-intermediate risk patients. However, TAVI may also serve as an alternative to SAVR in selected young patients, e.g., patients who have previously undergone multiple cardiac surgery procedures. We report a case of trans-femoral TAVI in a 25-year-old heart transplant (HTx) recipient with prior surgery for congenital heart disease.
Department of Cardiothoracic and Vascular Surgery & Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
Khalil
K
Ahmad
Department of Cardiology & Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
Christian Juhl
CJ
Terkelsen
Department of Cardiothoracic and Vascular Surgery & Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
Kim Allan
KA
Terp
Department of Cardiology & Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
Ole Norling
ON
Mathiassen
Department of Cardiology & Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
Bjarne Linde
BL
Nørgaard
Department of Cardiology & Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
Henning Rud
HR
Andersen
Department of Cardiology & Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
Steen Hvitfeldt
SH
Poulsen
Aorta stenosis; heart transplant (HTx); transcatheter aortic valve implantation (TAVI)